CrushSCI.com
Journal Selection & Manuscript Polishing Services
JOURNAL OF NEURO-ONCOLOGY journal cover Medicine
Back to journal directory

Review Cycle Records

JOURNAL OF NEURO-ONCOLOGY

Springer SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 22025 JCR Q2
50.6Average days
44Median days
15Fastest days
126Longest days
4712025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

50 days

Molecular therapy for papillary craniopharyngioma: a multi-institutional analysis of practice patterns across the RAPID Consortium

AuthorsMark A. Damante; Ryan B. Juncker; Andrew S. Little; Jamie J. Van Gompel; Sandhya Palit; Donato R. Pacione; Garni Barkhoudarian; Walavan Sivakumar; Spiros Blackburn; Michelle Magaña Mendoza; James J. Evans; Carolina Benjamin; Joshua D. Palmer; Pierre Giglio; Daniel M. Prevedello; Kyle C. Wu

Affiliations1. Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, USA; 2. College of Medicine, The Ohio State University, Columbus, USA; 3. Department of Neurological Surgery, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix, USA; 4. Department of Neurosurgery, Mayo Clinic, Rochester, USA; 5. Department of Neurosurgery, New York University, New York, USA; 6. Department of Neurosurgery, Pacific Neuroscience Institute, Providence St. Johns Medical Center, Santa Monica, USA; 7. Department of Neurosurgery, UT Health Houston, Houston, USA; 8. Neuroanalytics Center, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix, USA; 9. Department of Neurosurgery, Jefferson University, Philadelphia, USA; 10. Department of Neurological Surgery, Miller School of Medicine, University of Miami, Miami, USA; 11. Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, USA; 12. Division of Neuro-Oncology, Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, USA

Source PDF DOI Publisher page
75 days

Actin, connexin-43 and GAP-43 expression in gliomas: real-world associations with IDH status, tumor burden and survival

AuthorsAleksandrs Krigers; Matthias Demetz; Lisa Bergmeister; Patrizia Moser; Adelheid Woehrer; Claudius Thomé; Christian F. Freyschlag

Affiliations1. Department of Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria; 2. Institute of Pathology, Neuropathology & Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria

Source PDF DOI Publisher page
15 days

Racial and ethnic differences in presentation and postoperative recovery after transsphenoidal surgery for cushing disease

AuthorsCaleigh S. Roach; Vratko Himic; Richa Dahake; Khushi H. Shah; Victor M. Lu; Daniel Kreatsoulas; Arman Jahangiri; Carmen V. Villabona; Zoukaa B. Sargi; Ashish H. Shah; Carolina G. Benjamin; Ricardo J. Komotar; Michael E. Ivan

Affiliations1. Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, USA; 2. Department of Endocrinology, University of Miami Miller School of Medicine, Miami, USA; 3. Department of Otolaryngology - Head & Neck Surgery, University of Miami Miller School of Medicine, Miami, USA

Source PDF DOI Publisher page
34 days

Pediatric ependymoma in the molecular era: real-world experience with diagnostic correlation and long-term clinical outcomes

AuthorsKaterina Trkova; Ales Vicha; David Sumerauer; David R. Ghasemi; Vijay Ramaswamy; Lenka Krskova; Miroslav Koblizek; Josef Zamecnik; Martin Kyncl; Barbora Ondrova; Lucie Stolova; Marie Rybkova; Katarina Horcicakova; Vladimir Benes; Stefan Rutkowski; Michal Zapotocky

Affiliations1. Prague Brain Tumor Research Group, Second Faculty of Medicine, Charles University Prague and Motol and Homolka University Hospital, Prague, Czech Republic; 2. Center for Pediatric Neuro-Oncology, Motol and Homolka University Hospital, Prague, Czech Republic; 3. Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University Prague and Motol and Homolka University Hospital, Prague, Czech Republic; 4. Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 5. Research Institute Children’s Cancer Center, Hamburg, Germany; 6. Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 7. Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; 8. Development and Stem Cell Biology, Labatt Brain Tumour Research Centre, Sickkids Research Institute, Toronto, Canada; 9. Department of Medical Biophysics and Paediatrics, University of Toronto, Toronto, Canada; 10. Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada; 11. Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University Prague and Motol and Homolka University Hospital, Prague, Czech Republic; 12. Department of Radiology, Second Faculty of Medicine, Charles University Prague and Motol and Homolka University Hospital, Prague, Czech Republic; 13. Proton Therapy Center Czech, Prague, Czech Republic; 14. Department of Neurosurgery, Second Faculty of Medicine, Charles University Prague and Motol and Homolka University Hospital, Prague, Czech Republic

Source PDF DOI Publisher page
67 days

Multi-molecular saturation-transfer MR fingerprinting for differentiating tumor progression from treatment-related change in post-treatment IDH-wildtype glioblastoma: a feasibility study

AuthorsKevin Ju; Ji Eun Park; Sultan Z. Mahmud; Lindsay Blair; Doris D. M. Lin; Peter C. M. van Zijl; David O. Kamson; Hye-Young Heo

Affiliations1. Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, USA; 2. Department of Biomedical Engineering, Johns Hopkins University, Baltimore, USA; 3. Department of Neurology, Johns Hopkins University, Baltimore, USA; 4. F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, USA; 5. Department of Oncology, Johns Hopkins University, Baltimore, USA

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.